cefixime has been researched along with Infections, Respiratory in 56 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 560 patients were treated in two double-blind, randomized multicenter studies to compare the safety and efficacy of cefixime (400 mg administered once daily) and amoxicillin (250 or 500 mg administered three times daily) for the treatment of bacterial respiratory tract infections." | 10.16 | Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. ( Johnson, D; Kiani, R; Nelson, B, 1988) |
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 9.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "This randomized, double-blind multicenter study compared clarithromycin and cefixime as treatment for patients with community-acquired lower respiratory tract infections (n = 213)." | 9.07 | Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. ( Chick, TW; Neu, HC, 1993) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 9.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| "Cefixime is a new oral cephalosporin with the same activity as that of third generation cephalosporins, particularly against organisms responsible for lower respiratory tract infections." | 9.06 | [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study]. ( Modai, J, 1989) |
| "Sixty patients with lower respiratory tract infections, mainly acute bronchitis were treated for 14 days with either cefixime 200 mg twice daily (plus placebo once daily) or amoxicillin/clavulanic acid 500 mg/125 mg thrice daily in a double-blind manner." | 9.06 | Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. ( Beumer, HM, 1989) |
| "A randomized controlled study design was used to compare the efficacy of cefixime versus cefaclor in 30 patients suffering from lower respiratory tract infections." | 9.06 | Safety and efficacy of cefixime versus cefaclor in respiratory tract infections. ( Dorow, P, 1989) |
| "From October, 1993 to August, 1994, a post-marketing surveillance study enrolled 9,568 adults and children treated for respiratory tract infections with cefixime in a daily dose of 400 mg or 8 mg/kg body weight, respectively." | 7.69 | Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany. ( Hausen, T; Schmitt, J; Weidlich, G, 1995) |
| "Cefixime (CFIX) was evaluated clinically in pediatric respiratory tract infections, particularly those caused by Haemophilus influenzae: 1." | 7.68 | [Clinical evaluation of cefixime in pediatric respiratory tract infections]. ( Iwai, N; Kasai, K; Maki, T; Matsui, Y; Nakamura, H; Ozaki, T; Taneda, Y; Tauchi, N; Yamaguchi, H, 1991) |
| "Diagnoses included acute respiratory tract infections with no underlying pulmonary pathology (cefixime 21, amoxicillin 27), acute exacerbation of chronic obstructive lung disease (cefixime 32, amoxicillin 42), superinfection of viral bronchitis or lung cancer, and pleuritis (cefixime 10, amoxicillin 6)." | 6.66 | [Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults]. ( Hugues, FC; Le Jeunne, C, 1989) |
| "Cefixime is an orally active third generation cephalosporin with in vitro antibacterial activity against most important lower respiratory pathogens." | 6.39 | Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. ( Brogden, RN; Markham, A, 1995) |
| "A total of 560 patients were treated in two double-blind, randomized multicenter studies to compare the safety and efficacy of cefixime (400 mg administered once daily) and amoxicillin (250 or 500 mg administered three times daily) for the treatment of bacterial respiratory tract infections." | 6.16 | Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. ( Johnson, D; Kiani, R; Nelson, B, 1988) |
| "Cefixime is an oral third generation cephalosporin, frequently used in respiratory tract infections (RTI) in the pediatric population." | 5.15 | Clinical role of Cefixime in community-acquired infections. ( Aliu, A; Basha, N; Daka, A; Doda-Ejupi, T; Dreshaj, Sh; Geca, Nj; Kabashi, S; Mustafa, A; Shala, N; Tolaj, IQ, 2011) |
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 5.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "This randomized, double-blind multicenter study compared clarithromycin and cefixime as treatment for patients with community-acquired lower respiratory tract infections (n = 213)." | 5.07 | Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. ( Chick, TW; Neu, HC, 1993) |
| "Cefixime is a new oral cephalosporin with the same activity as that of third generation cephalosporins, particularly against organisms responsible for lower respiratory tract infections." | 5.06 | [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study]. ( Modai, J, 1989) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 5.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| "Sixty patients with lower respiratory tract infections, mainly acute bronchitis were treated for 14 days with either cefixime 200 mg twice daily (plus placebo once daily) or amoxicillin/clavulanic acid 500 mg/125 mg thrice daily in a double-blind manner." | 5.06 | Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. ( Beumer, HM, 1989) |
| "A randomized controlled study design was used to compare the efficacy of cefixime versus cefaclor in 30 patients suffering from lower respiratory tract infections." | 5.06 | Safety and efficacy of cefixime versus cefaclor in respiratory tract infections. ( Dorow, P, 1989) |
| "The clinical and laboratory safety of cefixime based on analysis of data from 1575 adults (1118 treated daily and 457 treated twice a day) and 615 children (299 treated daily and 316 treated twice a day) in studies of urinary tract and lower and upper respiratory tract infections (including otitis media) is reviewed." | 5.06 | Safety profile of cefixime. ( Cartwright, K; Desjardins, RE; McCarthy, EF; Tally, FP, 1987) |
| "From October, 1993 to August, 1994, a post-marketing surveillance study enrolled 9,568 adults and children treated for respiratory tract infections with cefixime in a daily dose of 400 mg or 8 mg/kg body weight, respectively." | 3.69 | Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany. ( Hausen, T; Schmitt, J; Weidlich, G, 1995) |
| "Against strains of Branhamella catarrhalis which were separated from various RTIs (respiratory tract infections) in 1991 antimicrobial activities (MICs) of cefetamet (CFMT) were determined, and the following conclusions were obtained." | 3.68 | [Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis]. ( Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N, 1992) |
| "Cefixime (CFIX) was evaluated clinically in pediatric respiratory tract infections, particularly those caused by Haemophilus influenzae: 1." | 3.68 | [Clinical evaluation of cefixime in pediatric respiratory tract infections]. ( Iwai, N; Kasai, K; Maki, T; Matsui, Y; Nakamura, H; Ozaki, T; Taneda, Y; Tauchi, N; Yamaguchi, H, 1991) |
| "In a pilot study with a limited number of patients the efficacy and tolerance of cefixime, a new oral cephalosporin antibiotic, were investigated in 15 children with the clinical diagnosis of bacterial respiratory tract infection, otitis media or urinary tract infection." | 3.68 | [Therapy of pediatric infections with cefixime]. ( Helwig, H, 1990) |
| "Cefixime (CFIX) was given orally to 25 children with acute bacterial infections including 13 with acute tonsillitis, 1 with acute tonsillitis and cervical lymphadenitis, 1 with acute bronchitis, 5 with bronchopneumonia and 5 with urinary tract infection." | 3.67 | [Clinical experience with cefixime in the pediatric field]. ( Aihara, R; Kobashi, H; Nishioka, A; Ohara, K; Okamoto, T, 1986) |
| "A clinical study of cefixime (CFIX), a new oral cephalosporin, was carried out to evaluate its therapeutic effectiveness on bacterial infections in children." | 3.67 | [Clinical studies on cefixime in pediatrics]. ( Endo, S; Hosoda, T; Masuda, M; Mimoto, H; Miyao, M; Tanaka, H; Yuasa, Y, 1986) |
| " Single doses of each agent were administered and serum concentrations were collected over the standard dosing period of 24 h for all study regimens." | 2.70 | Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens. ( Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P, 2001) |
| "478/1063 patients were treated for urinary tract infections (upper or lower UTI) with 200 mg cefixime bid; clinical cure was obtained in 92 and 96 per cent of upper and lower UTI respectively, and bacteriological cure in 97." | 2.66 | [Efficacy and tolerability of cefixime in international and French studies]. ( Carbon, C, 1989) |
| "Diagnoses included acute respiratory tract infections with no underlying pulmonary pathology (cefixime 21, amoxicillin 27), acute exacerbation of chronic obstructive lung disease (cefixime 32, amoxicillin 42), superinfection of viral bronchitis or lung cancer, and pleuritis (cefixime 10, amoxicillin 6)." | 2.66 | [Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults]. ( Hugues, FC; Le Jeunne, C, 1989) |
| "Cefixime is an orally active third generation cephalosporin with in vitro antibacterial activity against most important lower respiratory pathogens." | 2.39 | Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. ( Brogden, RN; Markham, A, 1995) |
| "Cefixime activity was not adversely influenced by several important variables such as pH (over the range from 5 to 8), inoculum size (from 10(5) to 10(8) CFU per ml) and the presence of 50% human serum or urine." | 1.28 | Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. ( Debbia, EA; Marchese, A; Pesce, A; Saverino, D; Schito, GC, 1992) |
| "86 hours and urinary excretions rates up to 12 hours after dosing were 16." | 1.27 | [Clinical studies of cefixime granules in pediatrics]. ( Chikaoka, H; Kamigaki, M; Koido, R; Matsumoto, K; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H, 1986) |
| "70 microgram/ml for a 3 mg/kg dosage and 2." | 1.27 | [Fundamental and clinical studies on cefixime in pediatrics]. ( Iwai, N; Katayama, M; Mizoguchi, F; Nakamura, H; Shibata, M, 1986) |
| "Cefixime (CFIX) was evaluated for pharmacokinetics, therapeutic effectiveness on infection, safety, and bacteriological effectiveness in pediatrics." | 1.27 | [Fundamental and clinical studies on cefixime in pediatric field]. ( Kida, K; Matsuda, H; Miyazaki, M; Murase, M, 1986) |
| "In 9 cases of respiratory infections, therapeutic results were excellent in 3 cases, good in 6 cases, and the effective rate was 100%." | 1.27 | [Fundamental and clinical studies of cefixime in children]. ( Nakayama, N; Tsuji, Y; Yanagishima, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (41.07) | 18.7374 |
| 1990's | 25 (44.64) | 18.2507 |
| 2000's | 4 (7.14) | 29.6817 |
| 2010's | 3 (5.36) | 24.3611 |
| 2020's | 1 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Ramdhani, D | 1 |
| Kusuma, SAF | 1 |
| Sediana, D | 1 |
| Bima, APH | 1 |
| Khumairoh, I | 1 |
| Anzellotti, F | 1 |
| Ricciardi, L | 1 |
| Monaco, D | 1 |
| Ciccocioppo, F | 1 |
| Borrelli, I | 1 |
| Zhuzhuni, H | 1 |
| Onofrj, M | 1 |
| Yilmaz, B | 1 |
| Ekız, F | 1 |
| Coban, S | 1 |
| Yüksel, I | 1 |
| Yüksel, O | 1 |
| Dreshaj, Sh | 1 |
| Doda-Ejupi, T | 1 |
| Tolaj, IQ | 1 |
| Mustafa, A | 1 |
| Kabashi, S | 1 |
| Shala, N | 1 |
| Geca, Nj | 1 |
| Aliu, A | 1 |
| Daka, A | 1 |
| Basha, N | 1 |
| Verhoef, J | 1 |
| Gillissen, A | 1 |
| Sengupta, J | 1 |
| Mondal, AK | 1 |
| Jain, P | 1 |
| Garg, RD | 1 |
| Mathur, NC | 1 |
| Moharana, AK | 1 |
| Capelli, O | 1 |
| Bonucchi, ME | 1 |
| Ragno, T | 1 |
| Azzolini, L | 1 |
| Prandi, E | 1 |
| Lega, M | 1 |
| Toraldo, MD | 1 |
| Velluti, G | 1 |
| Puxeddu, P | 1 |
| Cadoni, BM | 1 |
| Cadeddu, L | 1 |
| Brückner, O | 1 |
| Trautmann, M | 1 |
| Catena, E | 1 |
| Mistretta, A | 1 |
| Micillo, E | 1 |
| Crimi, N | 1 |
| Dericoloso, L | 1 |
| Tranchese, D | 1 |
| Barbagallo, S | 1 |
| Markham, A | 1 |
| Brogden, RN | 1 |
| Lieberman, D | 1 |
| Schlaeffer, F | 1 |
| Marcos Sánchez, F | 1 |
| Reinoso Cobo, D | 1 |
| García Camba, L | 1 |
| Celdrán Gil, JL | 1 |
| Vogel, F | 1 |
| Sereda, EV | 1 |
| Gusel', VA | 1 |
| Feshchenko, IuI | 1 |
| Ustinovich, AK | 1 |
| Zubovich, VK | 1 |
| Trofimov, VI | 1 |
| Nedostup, AV | 1 |
| Ovchinnikov, IuM | 1 |
| Pluzhnikov, MS | 1 |
| Darenkov, AF | 1 |
| Neu, HC | 1 |
| Chick, TW | 1 |
| Lehtonen, L | 1 |
| Huovinen, P | 1 |
| Hausen, T | 1 |
| Weidlich, G | 1 |
| Schmitt, J | 1 |
| Schito, GC | 2 |
| Debbia, EA | 2 |
| Pesce, A | 2 |
| Matsumoto, Y | 1 |
| de Lalla, F | 1 |
| Ludwig, E | 1 |
| Zhao, C | 1 |
| Li, J | 1 |
| Hao, F | 1 |
| Owens, RC | 1 |
| Tessier, P | 1 |
| Nightingale, CH | 1 |
| Ambrose, PG | 1 |
| Quintiliani, R | 1 |
| Nicolau, DP | 1 |
| Hamilton-Miller, JM | 1 |
| Borderon, JC | 1 |
| Bremond, M | 1 |
| Laugier, J | 1 |
| Despert, F | 1 |
| Marchese, A | 1 |
| Saverino, D | 1 |
| Deguchi, K | 1 |
| Yokota, N | 1 |
| Koguchi, M | 1 |
| Nakane, Y | 1 |
| Suzuki, Y | 1 |
| Fukayama, S | 1 |
| Ishihara, R | 1 |
| Oda, S | 1 |
| Di Nola, F | 1 |
| Arione, R | 1 |
| Bramato, C | 1 |
| Iwai, N | 2 |
| Nakamura, H | 3 |
| Kasai, K | 1 |
| Ozaki, T | 1 |
| Matsui, Y | 1 |
| Tauchi, N | 1 |
| Yamaguchi, H | 1 |
| Taneda, Y | 1 |
| Maki, T | 1 |
| Leonhardt, L | 1 |
| Theopold, M | 1 |
| Benner, U | 1 |
| Bauernfeind, A | 1 |
| Helwig, H | 1 |
| Verghese, A | 1 |
| Roberson, D | 1 |
| Kalbfleisch, JH | 1 |
| Sarubbi, F | 1 |
| McCarthy, M | 1 |
| Aarons, D | 1 |
| Scott, HV | 1 |
| Hugues, FC | 1 |
| Le Jeunne, C | 1 |
| Modai, J | 1 |
| Carbon, C | 1 |
| Beumer, HM | 1 |
| Mikawa, H | 1 |
| Mayumi, M | 1 |
| Akiyama, Y | 1 |
| Ito, S | 1 |
| Watanabe, Y | 1 |
| Kanaoka, H | 1 |
| Takeshita, S | 1 |
| Takahashi, Y | 1 |
| Akiyama, F | 1 |
| Yoshimura, T | 1 |
| Dorow, P | 1 |
| Kiani, R | 1 |
| Johnson, D | 1 |
| Nelson, B | 1 |
| Tally, FP | 1 |
| Desjardins, RE | 1 |
| McCarthy, EF | 1 |
| Cartwright, K | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Sohda, H | 1 |
| Yoshida, J | 1 |
| Togasaki, K | 1 |
| Fujii, R | 1 |
| Nakazawa, S | 2 |
| Sato, H | 1 |
| Narita, A | 1 |
| Suzuki, H | 1 |
| Matsumoto, K | 1 |
| Chikaoka, H | 1 |
| Kamigaki, M | 1 |
| Koido, R | 1 |
| Niino, K | 1 |
| Sunakawa, K | 1 |
| Saito, N | 1 |
| Ishizuka, Y | 1 |
| Iwata, S | 1 |
| Kumagai, N | 1 |
| Yokota, T | 1 |
| Asaishi, T | 1 |
| Kusano, S | 1 |
| Sato, Y | 1 |
| Kusumoto, Y | 1 |
| Toyonaga, Y | 1 |
| Sugita, M | 1 |
| Joh, K | 1 |
| Takahashi, T | 1 |
| Kurosu, Y | 1 |
| Hori, M | 1 |
| Shibata, M | 1 |
| Mizoguchi, F | 1 |
| Katayama, M | 1 |
| Furukawa, S | 1 |
| Okada, T | 1 |
| Aihara, R | 1 |
| Kobashi, H | 1 |
| Nishioka, A | 1 |
| Ohara, K | 1 |
| Okamoto, T | 1 |
| Hosoda, T | 1 |
| Masuda, M | 1 |
| Miyao, M | 1 |
| Mimoto, H | 1 |
| Endo, S | 1 |
| Yuasa, Y | 1 |
| Tanaka, H | 1 |
| Kurashige, T | 1 |
| Morita, H | 1 |
| Araki, K | 1 |
| Ogura, H | 1 |
| Morioka, N | 1 |
| Kitamura, I | 1 |
| Miyazaki, M | 1 |
| Kida, K | 1 |
| Matsuda, H | 1 |
| Murase, M | 1 |
| Nakayama, N | 1 |
| Yanagishima, M | 1 |
| Tsuji, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery[NCT05027893] | 157 participants (Actual) | Interventional | 2019-06-07 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for cefixime and Infections, Respiratory
| Article | Year |
|---|---|
Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime.
Topics: Anti-Bacterial Agents; Cefixime; Community-Acquired Infections; Haemophilus Infections; Haemophilus | 2003 |
Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clinical Trials as Topic; Humans; Microbial S | 1995 |
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemop | 2000 |
[Cefixime. Microbiologic, kinetic and clinical profile].
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Gonorrhea; Humans; Microbial Sensitivity Tests; Otitis Medi | 1991 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1988 |
19 trials available for cefixime and Infections, Respiratory
| Article | Year |
|---|---|
Clinical role of Cefixime in community-acquired infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Community-Acquired Infe | 2011 |
Comparative evaluation of cefpodoxime versus cefixime in children with lower respiratory tract infections.
Topics: Acute Disease; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Child; Child, Preschool; F | 2004 |
[Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; D | 1994 |
[Clinical efficacy of cefixime (results of multicenter trials)].
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Inf | 1993 |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Cefixime; Cefot | 1993 |
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; R | 1998 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escheric | 1997 |
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Com | 2001 |
[Treatment results using cefixime for bacterial respiratory tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Female; Humans; Male | 1990 |
[Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance; Female; Hu | 1990 |
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefixime; Cefotaxime; Cephalexin; Chronic Disease; Gram-Negative Bacteria | 1990 |
[Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind M | 1989 |
[Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Clinical Trials as | 1989 |
[Efficacy and tolerability of cefixime in international and French studies].
Topics: Cefixime; Cefotaxime; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Multicenter Studi | 1989 |
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; C | 1989 |
[Clinical studies on cefixime in pediatrics].
Topics: Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Ev | 1989 |
Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Female; Humans; Male; Mi | 1989 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1988 |
Safety profile of cefixime.
Topics: Adult; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Drug Admin | 1987 |
33 other studies available for cefixime and Infections, Respiratory
| Article | Year |
|---|---|
Comparative study of cefixime and tetracycline as an evaluation policy driven by the antibiotic resistance crisis in Indonesia.
Topics: Anti-Bacterial Agents; Bordetella; Cefixime; Corynebacterium; Disk Diffusion Antimicrobial Tests; Dr | 2021 |
Cefixime-induced nonconvulsive status epilepticus.
Topics: Anti-Bacterial Agents; Cefixime; Electroencephalography; Female; Humans; Middle Aged; Respiratory Tr | 2012 |
Cefixime-induced hepatotoxicity.
Topics: Abdominal Pain; Anti-Bacterial Agents; Cefixime; Chemical and Drug Induced Liver Injury; Female; Hum | 2011 |
Cefixime once-a-day in the treatment of lower respiratory tract infections in adults.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefixime; Drug Administration | 1989 |
Cefixime: comparative clinical trial on the treatment of upper respiratory tract infection and otitis in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalexin; Controlled Clinical Trials as Topic; | 1989 |
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as | 1989 |
Cefixime: comparative clinical trial on the treatment of lower respiratory tract infection in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchitis; Bronchopneumonia; Cefixime; Cephalexin; Clinic | 1989 |
Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bac | 1995 |
[Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Drug Tolerance; Huma | 1995 |
[Re-evaluation of current antimicrobials. Series 21: cefixime. Discussion].
Topics: Administration, Oral; Bacteria; Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; Respirator | 1994 |
Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Finland; Haemophilus influenzae; Humans; Microbial Sens | 1993 |
Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Respiratory Tra | 1995 |
Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Drug Resistance, Microbial; Europe; Humans; Lactams; Ma | 1996 |
[Infections in childhood; from respiratory infections to tropical medicine].
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Dexamethasone; Humans; Meningiti | 1993 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combinatio | 1998 |
Cefixime in the treatment of upper respiratory tract infections and otitis media.
Topics: Cefixime; Cefotaxime; Cephalosporins; Humans; Otitis Media; Patient Compliance; Penicillin Resistanc | 1998 |
[Effect of the administration of cefixime on aerobic fecal flora in children].
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Child, Preschool; Drug R | 1992 |
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Interactions; Enterobacteriaceae; Gram-Ne | 1992 |
[Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis].
Topics: beta-Lactamases; Cefixime; Cefotaxime; Cefotiam; Cefpodoxime; Ceftizoxime; Drug Resistance, Microbia | 1992 |
[Clinical evaluation of cefixime in pediatric respiratory tract infections].
Topics: Age Factors; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microb | 1991 |
[Therapy of pediatric infections with cefixime].
Topics: Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Lymphadeni | 1990 |
Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Humans; Microbial Sensitivity Tests; Respiratory Tract | 1990 |
[Clinical evaluation of cefixime in children].
Topics: Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Haemophilus Infections; | 1986 |
[Clinical studies of cefixime granules in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies of cefixime granules in pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infan | 1986 |
[Clinical experience with cefixime in the pediatric infections].
Topics: Acute Disease; Adolescent; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-L | 1986 |
[Clinical experience with cefixime in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchopneumonia; Cefixime; Cefotaxime; Child; Chil | 1986 |
[Clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Femal | 1986 |
[Fundamental and clinical studies of cefixime in children].
Topics: Administration, Oral; Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Inf | 1986 |